Citi kept its neutral/high risk rating and Dkr296 target on Novo, calling Lilly's trial results incrementally negative given similar stomach side effects.
Recap by typeshit. Full story at Yahoo! Finance Canada.
Novo reports nine-month results on Nov. 4, after a US judge declined its request to pause Lilly's weight-loss drug ads while the marketing dispute continues.
The Urban Zakapa singer shared gym-bound photos captioned with a call to go work out, as she focuses on exercise to hold her weight after stopping Wegovy.
The fitness creator argues people chase shortcuts and should handle walking, tracking food, water and 7 to 9 hours of sleep before adding peptides.
The Wegovy-sponsored CFL Division Finals kick off November 7 at 3:00 PM ET, the next step on the road to the Grey Cup.
12:24
Chiropractor Dr. Jones explains how he says nootropic peptides like Selank, Semax and Dihexa work. None of these are approved drugs in the US.
Lilly says it sees Mounjaro holding its leadership position going forward, part of its latest market commentary.
Loading…